Cargando…
Low-dose cyclooxygenase-2 (COX-2) inhibitor celecoxib plays a protective role in the rat model of neonatal necrotizing enterocolitis
This study aims to investigate the effects of the cyclooxygenase-2 (COX-2) inhibitor celecoxib on neonatal necrotizing enterocolitis (NEC) in rats. After treatment with a low dose of celecoxib (0.5, 1, or 1.5 mg/kg), pathological changes in the ileum and the levels of oxidative stress and inflammato...
Autor principal: | Sun, Ling |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8806921/ https://www.ncbi.nlm.nih.gov/pubmed/34546832 http://dx.doi.org/10.1080/21655979.2021.1980646 |
Ejemplares similares
-
Celecoxib: a selective cyclooxygenase-2 inhibitor
por: Gandelman, M
Publicado: (2003) -
Protective effects of different doses of human milk on neonatal necrotizing enterocolitis
por: Zhang, Baoquan, et al.
Publicado: (2020) -
Effects of a selective cyclooxygenase-2 inhibitor (celecoxib) on fracture healing in rats
por: Li, Kang-Hua, et al.
Publicado: (2013) -
Neonatal Necrotizing Enterocolitis
por: Gharpure, Vivek
Publicado: (2012) -
Neonatal Necrotizing Enterocolitis
por: Lahmiti, Saad, et al.
Publicado: (2011)